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Synthetic Schemes and Protocols
N 1 -((1r,3r,5r,7r)-Adamantan-2-yl)-N 2 -((E)-3,7-dimethylocta-2,6-dien-1-yl)eth-ane-1,2-diamine (1 ).
Compound 1 was made by following a reported procedure 2 . 1 H NMR (400 MHz, CDCl 3 ) δ 5.24 (t, J = 6.8 Hz, 1H), 5.07 (t, J = 7.2 Hz, 1H), 3.21 (d, J = 6.8 To a stirred solution of geranylamine (153 mg, 1.0 mmol) in CHCl 3 (3 mL), chloroacetyl chloride (167 mg, 1.5 mmol) was added drop-wise at 0 o C. Then water (2 mL) was added followed by K 2 CO 3 (414 mg, 3.0 mmol). A catalytic amount of tetrabutylammonium hydrogen sulfate was added to the reaction mixture which was then stirred for 4 h. After completion of the reaction, as monitored by TLC, the organic layer was separated and dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure. The residual mass was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the chloroacetamide (183 mg, 80%).
To a solution of 2-adamantanol (210 mg, 1.4 mmol) in dry THF (5 mL) was added NaH (washed and dried from hexane, 46 mg, 2 mmol) at 0 o C with stirring. After stirring for 30 min at 22 o C, the chloroacetamide (160 mg, 0.7 mmol) was added. Stirring was continued for 12hrs at 22 o C, then the reaction was quenched by adding saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the adamantanyloxyacetamide (150 mg, 62%).
To a suspension of LiAlH 4 (27 mg, 0.7 mmol) in dry THF (2 mL) was added adamantanyloxyacetamide (120 mg, 0.35 mmol) at 22 o C. Stirring was continued for 20 h at reflux, the reac-tion mixture cooled in an ice-bath and quenched by adding ammonium hydroxide (37%, 0.5 mL). Vigorous stirring was continued for 20 min. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography (using NH 4 OH (37%)/MeOH/EtOAc = 1/5/100 as eluent) to afford the product (74 mg, 64% O: C, 78.63; H, 11.25, N, 4.17. Found: C, 78.29; H, 11.00; N, 4.25 . Purity of the product (mesylate salt, obtained by neutralizing the product with 1 equivalent MeSO 3 H in CH 2 Cl 2 ) determined by qNMR: 96.6%. To a solution of 2-adamantylamine (187 mg, 1 mmol) and Et 3 N (0.42 mL, 3 mmol) in dry CH 2 Cl 2 (5 ml) was added 2-chloroacetyl chloride (95 µL, 1.2 mmol) with stirring at 0 o C. Stirring was continued for 2 h at 0 o C, then the volatile components were removed under reduced pressure. The residue was purified by flash chromatography (silica gel, hexane/ethyl acetate = 5/1) to give the product (184 mg, 81%). To a solution of geranyl alcohol (154 mg, 1 mmol) in dry THF (5 mL) was added NaH (washed with hexane, 30 mg, 1.2 mmol) with stirring at 0 o C. Stirring was continued for 30 minutes, then the above 2-chloroacetylamide (113 mg, 0.5 mmol) was added. After stirring for 6 h at 22 o C, the reaction was quenched by adding saturated NH 4 Cl (5 mL) and ethyl acetate (5 mL). The organic phase was separated and evaporated under reduced pressure. The residue was purified by flash chromatography (silica gel, hexane/ethyl acetate = 3/1) to give amide 9 (130 mg, 72%). To a solution of 9 (100 mg, 0.29 mmol) in dry Et 2 O (3 mL) was added LiAlH 4 (38 mg, 1 mmol) under N 2 . The reaction mixture was refluxed for 10 h and cooled to 22 o C. After adding NH 4 OH (28% in H 2 O, 0.5 mL), stirring was continued for 0.3 h. The ether phase was separated and evaporated to give a residue which was purified by flash chromatography (CHCl 3 /MeOH, 15/1) to give the product as a pale yellow oil (62 mg, 65%). 1 H NMR 5.34 (t, J = 6.8 Hz, 1H), 5.08 (t, J = 7.2 Hz, 1H), 4.00 (d, J = 7.2 Hz, 2H), 3.54 (t, J = 6.4 Hz, 2H), 2.74 (t, J = 6.4 Hz, 2H), 2.69 (s, 1H), 2.10-1.81 (m, 14H), NO: C, 79.70; H, 11.25, N, 4.22. Found: C, 79.75; H, 11.28; N, 4. 09.
(1r,3r,5r,7r)-2-(2-(((E)-3,7-Dimethylocta-2,6-dien-1-yl)oxy)ethoxy) adamantane (5).
To a suspension of NaH (washed and dried with hexane, 368 mg, 16 mmol) in THF (30 mL) was added 2-adamantanol (1.5 g, 10 mmol) at 0 o C. Stirring was continued for 30 min at 22 o C, then allylbromide (1.8 g, 15 mmol) was added. Stirring was continued for 3h at 22 o C, then the reaction was quenched by adding saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 5% EtOAc in hexane as eluent to afford the allyl ether (1.4 g, 75%).
To a suspension of the allyl ether (192 mg, 1 mmol) in MeCN/H 2 O/CCl 4 (2/3/2, 3.5 mL ) was added NaIO 4 (842 mg, 4 mmol), then RuCl 3 H 2 O (11 mg, 0.05 mmol). After stirring for 10h at 22 o C, dichloromethane (4 mL) was added. Separation and concentration of the organic phase under reduced pressure gave the crude acid which was then reduced by BH 3 SMe 2 to give the alcohol. To a solution of the alcohol (100 mg, 0.5 mmol) in dry THF (3 mL) was added NaH (washed with hexane, 17 mg, 0.75 mmol). After stirring for 30 min at 22 o C, geranyl bromide (162 mg, 0.75 mmol) was added. Stirring was continued for 10 h at 22 o C, then the reaction was quenched with saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 5% EtOAc in hexane as eluent to afford the product (139 mg, 84%). 5.33 (t, J = 6.4 Hz, 1H), 5.07 (t, J = 6.8 Hz, 1H), 4.04 (d, J = 6.4 Hz, 2H), 3.57 (s, 4H), 3.43 (s, 1H The allyl ether was converted to the acid by using a reported procedure 3 . To a solution of the acid (112 mg, 0.5 mmol) in CH 2 Cl 2 (3 mL) was added oxalyl chloride (0.08 mL, 1 mmol) and DMF (10 mg) with stirring at 0 o C. Stirring was continued for 1 h at 0 o C, then all volatile components were removed under reduced pressure to give the crude acid chloride. To a solution of S14 geranylamine (76 mg, 0.5 mmol) and Et 3 N (0.14 mL, 1 mmol) was added the acid chloride in dry CH 2 Cl 2 (1 mL) with stirring at 0 o C. Stirring was continued for 1 h at 0 o C then all volatile components were removed under reduced pressure. The residue was purified by flash chromatography (silca gel, hexane/ethyl acetate = 3/1) to give the amide (151 mg, 84%). To a solution of the amide in dry Et 2 O (6 mL) was added LiAlH 4 (76 mg, 2 mmol) under N 2 . The reaction was refluxed for 10 h and cooled to 22 o C. After NH 4 OH (28% in H 2 O, 1 mL) was added, stirring was continued for 0.3 h. The ether phase was separated and evaporated to give a residue which was purified with flash chromatography (CHCl 3 /MeOH, 15/1) to give the product as a pale yellow oil (99 mg, 67%). 1 H NMR 5.24 (t, J = 6.8 Hz, 1H), 5.07 (t, J = 7.2 Hz, 1H), 3.47 (t, J = 6.0 Hz, 2H), 3.37 (s, 1H), 3.20 (d, J = 6.8 Hz, 2H), 2.70 (t, J = 6.8 Hz, 2H), 2.08-1.97 (m, 8H), N-(2-((1r,3r,5r,7r )-Adamantan-2-yloxy)ethyl)-N,N,3,7-tetramethylocta-2,6-dien-1ammonium iodide (7).
To a solution of compound 3 (100 mg, 0.3 mmol) in MeCN (2 mL) at 22 o C was added K 2 CO 3 (138 mg, 1 mmol), followed by MeI (169 mg, 1.4 mmol). Stirring was continued for 3 days in the dark. Volatile material was removed under reduced pressure and dichloromethane was added. Filtration and concentration of the filtrate gave a product which was purified by washing with hexane, 133 mg (91%). ((1r,3r,5r,7r )-Adamantan-2-yloxy)-N-((E)-3,7-dimethylocta-2,6-dien-1-yl)acetamide (8).
2-
Compound 8 was made by following the same procedure as described for the synthesis of compound 3. 1 H NMR 6.60 (broad, 1H) 5.18 (t, J = 6.8 Hz, 1H), 5.05 (t, J = 6.8 Hz, 1H), 3 N-((1r,3r,5r,7r)-Adamantan-2-yl)-2-(((E)-3,7-dimethylocta-2,6-dien-1-yl) 
oxy)-acetamide (9).
Compound 9 was made by following the same procedure as described for the synthesis of 
(E)-N-(2-(tert-Butoxy)ethyl)-3,7-dimethylocta-2,6-dien-1-amine (10).
To a stirred solution of geranylamine (153 mg, 1.0 mmol) in CHCl 3 (3 mL), chloroacetyl chloride (167 mg, 1.5 mmol) was added drop-wise at 0 o C. Then water (2 mL) was added to the reaction mixture, followed by K 2 CO 3 (414 mg, 3.0 mmol). A catalytic amount of tetrabutylammonium hydrogen sulfate was added and the reaction mixture stirred for 4 h. After completion of the reaction, as monitored by TLC, the organic layer was separated and dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure. The residual mass was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the chloroacetamide (183 mg, 80%). To a solution of tert-butanol (206 mg, 2.8 mmol) in dry THF (5 mL) was added NaH (washed and dried from hexane, 92 mg, 4 mmol) at 0 o C, with stirring. After stirring for 30 min at 22 o C, the chloroacetamide (160 mg, 0.7 mmol) was added. Stirring was continued for 12 h at 22 o C, the reaction quenched by adding saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the tert-butyloxyacetamide (130 mg, 70%). To a suspension of LiAlH 4 (27 mg, 0.7 mmol) in dry THF (2 mL) was added tert-butyloxyacetamide (110 mg, 0.41 mmol) at 22 o C. Stirring was continued for 10 h at reflux, the reaction mixture was cooled in an ice-bath and quenched by adding ammonium hydroxide (37%, 0.2 mL). Vigorous stirring was continued for 20 min. Upon separation and concentration under reduced pressure, the residue was purified by S16 silica gel column chromatography (using NH 4 OH (37%)/MeOH/EtOAc = 1/5/100 as eluent) to afford the product (70 mg, 68%). 1 H NMR 5.24 (t, J = 5.6 Hz, 1H), 5.07 (t, J = 6.0 Hz, 1H), 3.46 (t, J = 4.2 Hz, 2H), 3.22 (d, J = 6.4 (E)-3,7-Dimethyl-N-(2-phenoxyethyl)octa-2,6-dien-1-amine (11) .
To a stirred solution of geranylamine (153 mg, 1.0 mmol) in CHCl 3 (3 mL), chloroacetyl chloride (167 mg, 1.5 mmol) was added drop-wise at 0 o C. Then water (2 mL) was added, followed by K 2 CO 3 (414 mg, 3.0 mmol) and a catalytic amount of tetrabutylammonium hydrogen sulfate. The reaction mixture was then stirred for 4 h. After completion of the reaction, as monitored by TLC, the organic layer was separated and dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure. The residual mass was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the chloroacetamide (183 mg, 80%). To a solution of phenol (188 mg, 2.0 mmol) in dry THF (6 mL) was added NaH (washed and dried from hexane, 72 mg, 3 mmol) at 0 o C with stirring. After stirring for 30 min at 22 o C, chloroacetamide (160 mg, 0.7 mmol) was added. Stirring was continued for 12 h at 22 o C and the reaction was quenched by adding saturated aqueous NH 4 Cl. After separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the phenyloxyacetamide (164 mg, 82%). To a suspension of LiAlH 4 (54 mg, 1.4 mmol) in dry THF (2 mL) was added phenyloxyacetamide (150 mg, 0.52 mmol) at 22 o C. Stirring was continued for 10 h at reflux, the reaction mixture was cooled in an ice-bath and quenched by adding ammonium hydroxide (37%, 0.2 mL). Vigorous stirring was continued for 20 min. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography (using NH 4 OH (37%)/MeOH/EtOAc = 1/5/100 as eluent) to afford the product (92 mg, 65%). 1 H NMR 7.25 (m, 2H), 6.90 (m, 3H), 5.25 (t, J = 6.8 Hz, 1H), 5.08 (t, J = 6.8 Hz, 1H) N-(2-(naphthalen-1-yloxy)ethyl)octa-2,6-dien-1-amine (12) .
To a stirred solution of geranylamine (153 mg, 1.0 mmol) in CHCl 3 (3 mL), chloroacetyl chloride (167 mg, 1.5 mmol) was added drop-wise at 0 o C. Then water (2 mL) followed by K 2 CO 3 (414 mg, 3.0 mmol) and a catalytic amount of tetrabutylammonium hydrogen sulfate were added and the reaction mixture stirred for 4 h. After completion of the reaction, as monitored by TLC, the organic layer was separated and dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure. The residual mass was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the chloroacetamide (183 mg, 80%). To a solution of naphthalen-1-ol (288 mg, 2.0 mmol) in dry THF (6 mL) was added NaH (washed and dried from hexane, 72 mg, 3 mmol) at 0 o C with stirring. After stirring for 30 min at 22 o C, chloroacetamide (160 mg, 0.7 mmol) was added. Stirring was continued for 12 h at 22 o C, then the reaction was quenched by adding saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the naphthalenyl oxyacetamide (174 mg, 74%). To a suspension of LiAlH 4 (54 mg, 1.4 mmol) in dry THF (2 mL) was added naphthalenyloxyacetamide (168 mg, 0.50 mmol) at 22 o C. Stirring was continued for 10 h at reflux, then the reaction mixture was cooled in an ice-bath and quenched by adding ammonium hydroxide (37%, 0.2 mL). Vigorous stirring was continued for 20 min. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography (using NH 4 OH (37%)/MeOH/EtOAc = 1/5/100 as eluent) to afford the product (96 mg, 60%). 1 H NMR 7.72 (m, 3H), 7.41 (t, J = 8.4 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.13 (d, J = 8.4 Hz, 1H), 7.12 (s, 1H), 5.28 (t, J = 6.8 Hz, 1H), 5.07 (t, J = 6.8 Hz, 1H), 4.18 (t, J = 4.2 Hz, 1H), 3.31 (d, J = 6.8 Hz, 2H) (((1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl) oxy)ethyl)octa-2,6-dien-1-amine (13).
S18
To a stirred solution of geranylamine (153 mg, 1.0 mmol) in CHCl 3 (3 mL) , chloroacetyl chloride (167 mg, 1.5 mmol) was added drop-wise at 0 o C. Then water (2 mL), K 2 CO 3 (414 mg, 3.0 mmol) and a catalytic amount of tetrabutylammonium hydrogen sulfate were added and the reaction mixture stirred for 4 h. After completion of the reaction, as monitored by TLC, the organic layer was separated and dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure. The residual mass was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the chloroacetamide (183 mg, 80%).
To a solution of (-)-borneol (308 mg, 2.0 mmol) in dry THF (6 mL) was added NaH (washed and dried from hexane, 72 mg, 3 mmol) at 0 o C with stirring. After stirring for 30 min at 22 o C, chloroacetamide (160 mg, 0.7 mmol) was added. Stirring was continued for 12 h at 22 o C, then the reaction was quenched by adding saturated NH 4 Cl. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography using 25% EtOAc in hexane as eluent to afford the bornyloxyacetamide (199 mg, 82%). To a suspension of LiAlH 4 (54 mg, 1.4 mmol) in dry THF (2 mL) was added bornyloxyacetamide (174 mg, 0.50 mmol) at 22 o C. Stirring was continued for 10 h at reflux, the reaction mixture cooled in an icebath and quenched by adding ammonium hydroxide (37%, 0.2 mL). Vigorous stirring was continued for 20 min. Upon separation and concentration under reduced pressure, the residue was purified by silica gel column chromatography (using NH 4 OH (37%)/MeOH/EtOAc = 1/5/100 as eluent) to afford the product (108 mg, 65%). 1 H NMR 5.20 (t, J = 6.8 Hz, 1H), 5.03 (t, J =J = 6.4 Hz, 1H), 3 , 10.90, N, 3.79. Found: C, 71.16; H, 11.48 
